Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,589 | 20 | 53.3% |
| Food and Beverage | $18,775 | 749 | 24.0% |
| Consulting Fee | $9,980 | 4 | 12.8% |
| Travel and Lodging | $4,508 | 23 | 5.8% |
| Honoraria | $2,500 | 1 | 3.2% |
| Education | $745.45 | 33 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kyowa Kirin, Inc. | $22,522 | 33 | $0 (2024) |
| Helsinn Therapeutics (U.S.), Inc. | $17,900 | 21 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $9,166 | 36 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $4,875 | 11 | $0 (2017) |
| Seattle Genetics, Inc. | $3,952 | 14 | $0 (2017) |
| ABBVIE INC. | $2,659 | 118 | $0 (2024) |
| Janssen Biotech, Inc. | $2,605 | 69 | $0 (2024) |
| PFIZER INC. | $2,102 | 19 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,492 | 40 | $0 (2024) |
| Journey Medical Corporation | $1,446 | 64 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,074 | 121 | Kyowa Kirin, Inc. ($15,766) |
| 2023 | $15,310 | 172 | Kyowa Kirin, Inc. ($6,562) |
| 2022 | $13,746 | 133 | Helsinn Therapeutics (U.S.), Inc. ($9,798) |
| 2021 | $7,736 | 76 | Helsinn Therapeutics (U.S.), Inc. ($6,612) |
| 2020 | $731.72 | 30 | Journey Medical Corporation ($279.21) |
| 2019 | $3,664 | 91 | Helsinn Therapeutics (U.S.), Inc. ($1,480) |
| 2018 | $2,309 | 123 | Mayne Pharma Inc. ($428.51) |
| 2017 | $10,527 | 84 | Actelion Pharmaceuticals US, Inc. ($4,875) |
All Payment Transactions
830 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 12/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $91.29 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.85 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $51.87 | General |
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Travel and Lodging | Cash or cash equivalent | $130.65 | General |
| Category: Monoclonal Antibody | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Immunology | ||||||
| 11/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Monoclonal Antibody | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,468 | 2,275 | $294,292 | $96,911 |
| 2022 | 16 | 1,803 | 3,113 | $346,453 | $125,599 |
| 2021 | 17 | 1,670 | 2,924 | $337,943 | $128,822 |
| 2020 | 15 | 1,253 | 1,996 | $229,168 | $84,572 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 384 | 464 | $71,938 | $24,479 | 34.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 67 | 81 | $42,230 | $17,070 | 40.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 204 | 232 | $40,389 | $14,367 | 35.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 224 | 275 | $30,632 | $8,319 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 123 | $27,058 | $7,913 | 29.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 91 | 101 | $19,320 | $6,986 | 36.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 53 | 65 | $27,308 | $5,985 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 153 | 728 | $7,862 | $3,135 | 39.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $8,841 | $2,515 | 28.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 55 | $4,888 | $2,004 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,887 | $1,691 | 34.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 36 | $3,464 | $1,160 | 33.5% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $4,110 | $904.26 | 22.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 13 | $1,239 | $364.58 | 29.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 25 | $125.00 | $19.20 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 455 | 585 | $90,811 | $33,460 | 36.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 210 | 241 | $41,956 | $15,473 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 172 | $37,727 | $14,176 | 37.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 51 | 54 | $28,153 | $11,876 | 42.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 146 | 160 | $30,532 | $11,797 | 38.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 281 | 350 | $38,987 | $11,484 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $17,482 | $6,253 | 35.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 193 | 1,108 | $11,966 | $5,028 | 42.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 27 | 33 | $9,211 | $3,928 | 42.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 37 | 40 | $16,805 | $3,585 | 21.3% |
About Dr. Stephanie Fabbro, M.D
Dr. Stephanie Fabbro, M.D is a Dermatology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1164798500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Fabbro, M.D has received a total of $78,097 in payments from pharmaceutical and medical device companies, with $24,074 received in 2024. These payments were reported across 830 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,589).
As a Medicare-enrolled provider, Fabbro has provided services to 6,194 Medicare beneficiaries, totaling 10,308 services with total Medicare billing of $435,904. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Columbus, OH
- Active Since 03/29/2012
- Last Updated 03/27/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164798500
Products in Payments
- Poteligeo (Drug) $22,328
- VALCHLOR (Drug) $17,900
- VALCHLOR MECHLORETHAMINE (Drug) $4,875
- SGN35 (Biological) $3,922
- TREMFYA (Drug) $1,936
- CIBINQO (Drug) $1,905
- VTAMA (Drug) $1,492
- RINVOQ (Biological) $1,268
- COSENTYX (Biological) $931.12
- Sotyktu (Drug) $847.32
- DUPIXENT (Biological) $785.72
- Otezla (Drug) $761.09
- TALTZ (Drug) $728.82
- SKYRIZI (Biological) $563.55
- DORYX (Drug) $532.58
- Erivedge (Biological) $420.93
- REMICADE (Biological) $369.55
- Humira (Biological) $363.34
- Tremfya (Drug) $313.44
- OPZELURA (Drug) $269.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Columbus
Dr. Michael Sheehan, M.d, M.D
Dermatology — Payments: $311,374
Benjamin Kaffenberger, Md, MD
Dermatology — Payments: $108,563
Dr. Shari Hicks-Graham, M.d, M.D
Dermatology — Payments: $74,753
Dr. Jessica Kaffenberger, M.d, M.D
Dermatology — Payments: $64,937
Peter Neidenbach, Md, MD
Dermatology — Payments: $40,935
Dr. Benjamin Bogucki, M.d, M.D
Dermatology — Payments: $23,666